Thread View: alt.support.musc-dystrophy
1 messages
1 total messages
Started by Pam Bower
Wed, 25 Feb 1998 00:00
CLINICAL STUDY: Ataxia-Telangiectasia
Author: Pam Bower
Date: Wed, 25 Feb 1998 00:00
Date: Wed, 25 Feb 1998 00:00
86 lines
4432 bytes
4432 bytes
STUDY: Effect of myo-Inositol on Cerebellar and Immune
Function in Patients with Ataxia-Telangiectasia
STUDY LOCATION: The Children's Hospital of Philadelphia (CHOP)
34th Street & Civic Center Boulevard
Philadelphia, Pennsylvania USA 19104-4399
PRINCIPLE INVESTIGATOR: Gerard Berry, M.D. (Metabolism/Biochemical Genetics)
CO-INVESTIGATORS: Peter Bingham, M.D. (Neurology)
Kathleen Sullivan, M.D., Ph.D. (Immunology)
FOCUS OF STUDY: Investigation of pharmacological doses of a
nutrient, identified as deficient in patients with
A-T, with critical roles in cell signaling and
cellular metabolism. Pre and post-assessment of
immune, neurological and activities of daily living
functioning.
STUDY DESIGN: Double blind placebo-controlled randomized-crossover
study.
FUNDING SOURCE: NIH Clinical Research Center Funds
WHAT IS REQUIRED: Four(4) trips to Philadelphia:
- 5 days at CHOP for "pre" measurements &
establishment of therapeutic dose of the
intervention per your child's weight and metabolism.
- Return home with liquid intervention.
- Take either placebo or nutrient for 1 month (both
pleasant tasting).
- 2 days at CHOP 1 month later for "post"
measurements.
- at least 1 week in-between, then repeat steps 1-4.
COST: - No cost for study and assessments.
- Minimal out-of-pocket for meals, recreation.
- Lodging at Ronald McDonald House.
- Assistance with airfares provided by The A-T
Project (Austin) with support from The A-T Medical
Research Foundation (Los Angeles).
BENEFITS OF STUDY: To participants & families:
- Complete immune & neurological work-ups including
brain MRI.
- Determination of your child's A-T genotype
- Upon study completion, details of your child's
neurological and immune response to the intervention.
To all affected by A-T:
- Contributing to treatment options for A-T.
- Correlation of phenotype(symptoms & seriousness)
with genotype.
- Determination of levels of critical cell signaling
phospholipids in specific cell membranes(never before
measured).
CONTACT: Gerard Berry, M.D. 215-590-3372
Michelle Bergman, R.N. 215-590-1399 - Clinical
Research Center Coordinatior (Ms. Bergman can
provide referrals to other families who have
participated).
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Pam Bower <pbower@inforamp.net>
InterNAF Board Member
Halifax, Nova Scotia Canada
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
INTERnational Network of Ataxia Friends
http://internaf.merseyside.org/
To subscribe to InterNAF
send an email to: Majordomo@connect.org.uk
with a one line message: Subscribe InterNAF
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Thread Navigation
This is a paginated view of messages in the thread with full content displayed inline.
Messages are displayed in chronological order, with the original post highlighted in green.
Use pagination controls to navigate through all messages in large threads.
Back to All Threads